| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.71B | 11.73B | 10.58B | 10.24B | 9.28B | 8.31B |
| Gross Profit | 5.29B | 5.39B | 5.22B | 5.05B | 4.68B | 4.58B |
| EBITDA | 3.15B | 3.33B | 3.06B | 2.77B | 2.38B | 2.05B |
| Net Income | 1.20B | 1.11B | 1.18B | 1.17B | 962.76M | 943.56M |
Balance Sheet | ||||||
| Total Assets | 10.47B | 12.43B | 11.15B | 9.62B | 8.29B | 7.46B |
| Cash, Cash Equivalents and Short-Term Investments | 3.02B | 3.01B | 1.73B | 1.90B | 1.44B | 979.40M |
| Total Debt | 0.00 | 1.25B | 0.00 | 314.55M | 314.55M | 514.55M |
| Total Liabilities | 1.86B | 3.05B | 2.64B | 2.28B | 2.10B | 2.21B |
| Stockholders Equity | 8.52B | 9.29B | 8.43B | 7.25B | 6.10B | 5.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.45B | 2.04B | 1.85B | 1.99B | 641.94M |
| Operating Cash Flow | 0.00 | 1.59B | 2.11B | 1.97B | 2.31B | 698.24M |
| Investing Cash Flow | 0.00 | -1.29B | -1.97B | -1.50B | -1.65B | -1.67B |
| Financing Cash Flow | 0.00 | 968.00M | -312.95M | 825.00K | -199.91M | 493.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥38.91B | 15.09 | 19.71% | 3.09% | 9.27% | 48.93% | |
79 Outperform | ¥26.64B | 16.94 | ― | ― | 13.54% | 54.38% | |
75 Outperform | ¥18.65B | 20.46 | ― | 0.17% | 29.37% | 66.06% | |
74 Outperform | ¥54.10B | 85.62 | ― | ― | 38.15% | 78.39% | |
73 Outperform | ¥24.91B | 22.53 | ― | ― | 10.88% | -5.32% | |
68 Neutral | ¥35.95B | 23.82 | ― | 0.39% | 22.45% | 23.34% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |